[(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(recent cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk,1.0), (Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,risk among contraception users,1.0), (cohort study,reported,20 % risk among current contraception users,1.0), (recent cohort study,reported,20 % risk,1.0), (Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk,1.0), (cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,risk of breast cancer,1.0), (recent Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,risk,1.0), (Danish cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among current contraception users,1.0), (Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,risk among contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,risk among hormonal contraception users,1.0), (cohort study,reported,risk of breast cancer among contraception users,1.0), (recent cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,increased risk,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,20 % increased risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer,1.0), (cohort study,reported,increased risk,1.0), (Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer,1.0), (cohort study,reported,risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,risk among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,risk,1.0), (recent cohort study,reported,risk of breast cancer,1.0), (cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk among contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk,1.0), (Danish cohort study,reported,20 % risk among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % risk among current hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among hormonal contraception users,1.0), (recent cohort study,reported,risk of breast cancer among contraception users,1.0), (cohort study,reported,risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (recent cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk among hormonal contraception users,1.0), (cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,increased risk among hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk,1.0), (recent Danish cohort study,reported,20 % risk among hormonal contraception users,1.0), (recent Danish cohort study,reported,increased risk of breast cancer,1.0), (recent Danish cohort study,reported,20 % risk among current contraception users,1.0), (recent Danish cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % risk,1.0), (recent Danish cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk of breast cancer among contraception users,1.0), (Danish cohort study,reported,20 % risk of breast cancer,1.0), (recent cohort study,reported,increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk among contraception users,1.0), (cohort study,reported,increased risk among current contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer,1.0), (Danish cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (recent cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % risk among contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer,1.0), (cohort study,reported,20 % risk among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among contraception users,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current hormonal contraception users,1.0), (recent Danish cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer,1.0), (recent cohort study,reported,20 % risk among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % increased risk of breast cancer among contraception users,1.0), (cohort study,reported,20 % risk of breast cancer among current contraception users,1.0), (Danish cohort study,reported,20 % increased risk among contraception users,1.0), (recent cohort study,reported,increased risk among current contraception users,1.0), (cohort study,reported,increased risk among current hormonal contraception users,1.0), (cohort study,reported,risk,1.0), (recent cohort study,reported,risk,1.0), (recent Danish cohort study,reported,20 % risk of breast cancer,1.0), (Danish cohort study,reported,20 % risk among current hormonal contraception users,1.0), (Danish cohort study,reported,20 % risk,1.0), (recent cohort study,reported,risk of breast cancer among hormonal contraception users,1.0), (cohort study,reported,20 % increased risk of breast cancer among current contraception users,1.0), (cohort study,reported,20 % risk,1.0), (recent cohort study,reported,20 % risk among contraception users,1.0), (Danish cohort study,reported,risk of breast cancer among current contraception users,1.0), (cohort study,reported,increased risk of breast cancer among hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among current hormonal contraception users,1.0), (cohort study,reported,20 % increased risk among current contraception users,1.0), (recent cohort study,reported,risk of breast cancer among current hormonal contraception users,1.0), (Danish cohort study,reported,increased risk of breast cancer among contraception users,1.0), (recent cohort study,reported,increased risk among contraception users,1.0), (recent cohort study,reported,20 % risk of breast cancer,1.0)][(results,are,consistent,1.0), (results,are largely consistent with,studies,1.0), (results,are largely consistent with,previous studies,1.0), (results,are consistent with,studies,1.0), (results,are,largely consistent,1.0), (results,are consistent with,previous studies,1.0)][(results,are,consistent,1.0), (results,are largely consistent with,studies,1.0), (results,are largely consistent with,previous studies,1.0), (results,are consistent with,studies,1.0), (results,are,largely consistent,1.0), (results,are consistent with,previous studies,1.0)][(results,are,consistent,1.0), (results,are largely consistent with,studies,1.0), (results,are largely consistent with,previous studies,1.0), (results,are consistent with,studies,1.0), (results,are,largely consistent,1.0), (results,are consistent with,previous studies,1.0)][(results,are,consistent,1.0), (results,are largely consistent with,studies,1.0), (results,are largely consistent with,previous studies,1.0), (results,are consistent with,studies,1.0), (results,are,largely consistent,1.0), (results,are consistent with,previous studies,1.0)][(results,are,consistent,1.0), (results,are largely consistent with,studies,1.0), (results,are largely consistent with,previous studies,1.0), (results,are consistent with,studies,1.0), (results,are,largely consistent,1.0), (results,are consistent with,previous studies,1.0)][(results,are,consistent,1.0), (results,are largely consistent with,studies,1.0), (results,are largely consistent with,previous studies,1.0), (results,are consistent with,studies,1.0), (results,are,largely consistent,1.0), (results,are consistent with,previous studies,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(They,did find,increased risk,1.0), (They,did find,risk with use of levonorgestrel system-both of potentially important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use of levonorgestrel system-both of findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both,1.0), (They,did find,risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both of findings,1.0), (increased risk,is with,use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk with use of levonorgestrel system-both,1.0), (They,did find,increased risk with use,1.0), (They,did find,increased risk with use of levonorgestrel system-both,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of findings,1.0), (risk,is in,current users of longer duration,1.0), (They,did find,risk with use of levonorgestrel system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel intrauterine system-both of findings,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of potentially important findings,1.0), (They,did find,risk,1.0), (They,did find,risk,1.0), (They,did find,risk with use of levonorgestrel intrauterine system-both of important findings,1.0), (They,did find,increased risk with use of levonorgestrel system-both of potentially important findings,1.0)][(hormonal contraception use,has,has found,1.0), (contraception use,has,has found,1.0), (breast cancer effects,described in,studies,0.5154081111901481), (breast cancer effects,described now in,studies,0.5154081111901481), (hormonal contraception use,has,in term has found,1.0), (breast cancer effects,described now in,multiple studies,0.5154081111901481), (contraception use,has,in long term has found,1.0), (contraception use,has,in term has found,1.0), (hormonal contraception use,has,in long term has found,1.0), (breast cancer effects,wane with,time,1.0), (breast cancer effects,described in,multiple studies,0.5154081111901481)][(hormonal contraception use,has,has found,1.0), (contraception use,has,has found,1.0), (breast cancer effects,described in,studies,0.5154081111901481), (breast cancer effects,described now in,studies,0.5154081111901481), (hormonal contraception use,has,in term has found,1.0), (breast cancer effects,described now in,multiple studies,0.5154081111901481), (contraception use,has,in long term has found,1.0), (contraception use,has,in term has found,1.0), (hormonal contraception use,has,in long term has found,1.0), (breast cancer effects,wane with,time,1.0), (breast cancer effects,described in,multiple studies,0.5154081111901481)][(hormonal contraception use,has,has found,1.0), (contraception use,has,has found,1.0), (breast cancer effects,described in,studies,0.5154081111901481), (breast cancer effects,described now in,studies,0.5154081111901481), (hormonal contraception use,has,in term has found,1.0), (breast cancer effects,described now in,multiple studies,0.5154081111901481), (contraception use,has,in long term has found,1.0), (contraception use,has,in term has found,1.0), (hormonal contraception use,has,in long term has found,1.0), (breast cancer effects,wane with,time,1.0), (breast cancer effects,described in,multiple studies,0.5154081111901481)][(hormonal contraception use,has,has found,1.0), (contraception use,has,has found,1.0), (breast cancer effects,described in,studies,0.5154081111901481), (breast cancer effects,described now in,studies,0.5154081111901481), (hormonal contraception use,has,in term has found,1.0), (breast cancer effects,described now in,multiple studies,0.5154081111901481), (contraception use,has,in long term has found,1.0), (contraception use,has,in term has found,1.0), (hormonal contraception use,has,in long term has found,1.0), (breast cancer effects,wane with,time,1.0), (breast cancer effects,described in,multiple studies,0.5154081111901481)][(hormonal contraception use,has,has found,1.0), (contraception use,has,has found,1.0), (breast cancer effects,described in,studies,0.5154081111901481), (breast cancer effects,described now in,studies,0.5154081111901481), (hormonal contraception use,has,in term has found,1.0), (breast cancer effects,described now in,multiple studies,0.5154081111901481), (contraception use,has,in long term has found,1.0), (contraception use,has,in term has found,1.0), (hormonal contraception use,has,in long term has found,1.0), (breast cancer effects,wane with,time,1.0), (breast cancer effects,described in,multiple studies,0.5154081111901481)][(hormonal contraception use,has,has found,1.0), (contraception use,has,has found,1.0), (breast cancer effects,described in,studies,0.5154081111901481), (breast cancer effects,described now in,studies,0.5154081111901481), (hormonal contraception use,has,in term has found,1.0), (breast cancer effects,described now in,multiple studies,0.5154081111901481), (contraception use,has,in long term has found,1.0), (contraception use,has,in term has found,1.0), (hormonal contraception use,has,in long term has found,1.0), (breast cancer effects,wane with,time,1.0), (breast cancer effects,described in,multiple studies,0.5154081111901481)][(hormonal contraception use,has,has found,1.0), (contraception use,has,has found,1.0), (breast cancer effects,described in,studies,0.5154081111901481), (breast cancer effects,described now in,studies,0.5154081111901481), (hormonal contraception use,has,in term has found,1.0), (breast cancer effects,described now in,multiple studies,0.5154081111901481), (contraception use,has,in long term has found,1.0), (contraception use,has,in term has found,1.0), (hormonal contraception use,has,in long term has found,1.0), (breast cancer effects,wane with,time,1.0), (breast cancer effects,described in,multiple studies,0.5154081111901481)][(hormonal contraception use,has,has found,1.0), (contraception use,has,has found,1.0), (breast cancer effects,described in,studies,0.5154081111901481), (breast cancer effects,described now in,studies,0.5154081111901481), (hormonal contraception use,has,in term has found,1.0), (breast cancer effects,described now in,multiple studies,0.5154081111901481), (contraception use,has,in long term has found,1.0), (contraception use,has,in term has found,1.0), (hormonal contraception use,has,in long term has found,1.0), (breast cancer effects,wane with,time,1.0), (breast cancer effects,described in,multiple studies,0.5154081111901481)][(hormonal contraception use,has,has found,1.0), (contraception use,has,has found,1.0), (breast cancer effects,described in,studies,0.5154081111901481), (breast cancer effects,described now in,studies,0.5154081111901481), (hormonal contraception use,has,in term has found,1.0), (breast cancer effects,described now in,multiple studies,0.5154081111901481), (contraception use,has,in long term has found,1.0), (contraception use,has,in term has found,1.0), (hormonal contraception use,has,in long term has found,1.0), (breast cancer effects,wane with,time,1.0), (breast cancer effects,described in,multiple studies,0.5154081111901481)][(hormonal contraception use,has,has found,1.0), (contraception use,has,has found,1.0), (breast cancer effects,described in,studies,0.5154081111901481), (breast cancer effects,described now in,studies,0.5154081111901481), (hormonal contraception use,has,in term has found,1.0), (breast cancer effects,described now in,multiple studies,0.5154081111901481), (contraception use,has,in long term has found,1.0), (contraception use,has,in term has found,1.0), (hormonal contraception use,has,in long term has found,1.0), (breast cancer effects,wane with,time,1.0), (breast cancer effects,described in,multiple studies,0.5154081111901481)][(hormonal contraception use,has,has found,1.0), (contraception use,has,has found,1.0), (breast cancer effects,described in,studies,0.5154081111901481), (breast cancer effects,described now in,studies,0.5154081111901481), (hormonal contraception use,has,in term has found,1.0), (breast cancer effects,described now in,multiple studies,0.5154081111901481), (contraception use,has,in long term has found,1.0), (contraception use,has,in term has found,1.0), (hormonal contraception use,has,in long term has found,1.0), (breast cancer effects,wane with,time,1.0), (breast cancer effects,described in,multiple studies,0.5154081111901481)]